Home
Interesting shortcuts
EFFRA Members' Perspectives
News Dashboard
Projects
Projects
Results, demos etc.
Results, demos etc.
Structured Wiki
Search
FoF and Made in Europe Partnership
Demonstrators, pilots, prototypes
Exploitable result(s)
Significant innovations and lessons learned, training aspects
Report - Video - Presentation - Publication....?
Project clusters
Company perspectives
Manufacturing future products
Manufacturing performance characteristics
Technologies and enablers
ICT performance characteristics
Standards and standardisation
Contribution of R&I projects to standardisation
Regulatory and policy aspects
Standards - other classifications
Business model aspects
Pathways
MiE SRIA R&I Priorities
Public Consultation - MiE 25-27 Priorities (input is publicly available)
MiE KPIs
Relevant open calls
EU-Programme-Call
NACE code
EFFRA WG pointers
Pathways
Pathways
Project ideas
Project ideas
People & organisations
People
Organisations
portal@effra.eu
Visit the EFFRA website
Login
Projects
MAASive
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.0. Cross-cutting call topics
MAASive
mapped on
H2020-EU.3.1.0. Cross-cutting call topics
H2020-Adhoc-2014-20
Health Health
H2020-HCO-2014
HCO-14-2014 Bridging the divide in European health research and innovation
HCO-15-2014 Mobilisation and mutual learning action plan
HCO-16-2014 National contact points
H2020-IBA-SC1-BIOMEDICAL-2017
IBA-SC1-BIOMEDICAL-2017
H2020-IBA-SC1-CORONAVIRUS-2020-4
IBA-SC1-CORONAVIRUS-2020-4 EU-wide Covid-19 vaccine trial network
H2020-IBA-SC1-eHealth-2017
IBA-SC1-eHealth-2017
H2020-IBA-SC1-Presidency-2020
IBA-SC1-Presidency-2020
H2020-JTI-IMI2-2015-08-single-stage
IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
H2020-JTI-IMI2-2020-20-two-stage
IMI2-2020-20-01 Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
IMI2-2020-20-02 Innovations to accelerate vaccine development vaccine development and manufacture
IMI2-2020-20-03 Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
IMI2-2020-20-04 Tumour plasticity
IMI2-2020-20-05 Proton versus photon therapy for oesophageal cancer - a trimodality strategy
IMI2-2020-20-06 Handling of protein drug products and stability concerns
H2020-JTI-IMI2-2020-22-single-stage
IMI2-2020-22-01 Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
SC1-BHC-37-2020 Towards the new generation of clinical trials ? trials methodology research
H2020-JTI-IMI2-2020-23-two-stage
IMI2-2020-23-01 Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework
IMI2-2020-23-02 Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
IMI2-2020-23-03 A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
IMI2-2020-23-04 Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence
IMI2-2020-23-05 Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies
IMI2-2020-23-06 Behavioural Model of Factors Affecting Patient Adherence
H2020-PHC-2014-single-stage
PHC-20-2014 Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment
PHC-26-2014 Self management of health and disease: citizen engagement and mHealth
H2020-SC1-2020-Single-Stage-RTD
SC1-BHC-06-2020 Digital diagnostics ? developing tools for supporting clinical decisions by integrating various diagnostic data
SC1-BHC-11-2020 Advancing the safety assessment of chemicals without the use of animal testing
SC1-BHC-17-2020 Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions
SC1-BHC-33-2020 Addressing low vaccine uptake
SC1-BHC-34-2020 New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
SC1-BHC-35-2020 Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
SC1-BHC-36-2020 Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
SC1-DTH-12-2020 Use of Real-World Data to advance research on the management of complex chronic conditions
SC1-HCC-10-2020 Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
SC1-HCO-03-2020 Bridging the divide in health research and innovation ? boosting return on investment
SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
SC1-HCO-14-2020 ERA-NET: Sustained collaboration of national and regional programmes in cancer research
SC1-HCO-16-2020 ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
SC1-HCO-18-2020 Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
SC1-HCO-20-2020 Coordination of clinical research activities of the European Reference Networks
SGA-SC1-CEPI-2020 Grant to the Coalition for Epidemic Preparedness Innovations (CEPI)
H2020-SC1-2020-Two-Stage-RTD
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-29-2020 Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors
SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
H2020-SC1-DTH-2020-1
SC1-DTH-02-2020 Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies
SC1-DTH-04-2020 International cooperation in smart living environments for ageing people
SC1-DTH-06-2020 Accelerating the uptake of computer simulations for testing medicines and medical devices
SC1-DTH-14-2020 Pre-commercial Procurement for Digital Health and Care Solutions
SC1-HCC-08-2020 Scaling up innovation for active and healthy ageing
SC1-HCC-09-2020 Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes
H2020-SC1-FA-DTS-2020-1
DT-TDS-04-2020 AI for Genomics and Personalised Medicine
H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
SC1-PHE-CORONAVIRUS-2020-2B
H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
SC1-BHC-08-2020 New interventions for Non-Communicable Diseases
SC1-PHE-CORONAVIRUS-2020-2C Behavioural, social and economic impacts of the outbreak response
SC1-PHE-CORONAVIRUS-2020-2D Pan-European COVID-19 cohorts
SC1-PHE-CORONAVIRUS-2020-2E Networking of existing EU and international cohorts of relevance to COVID-19
H2020-SMEINST-1-2014
PHC-12-2014-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2015
PHC-12-2015 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector